Track insider transactions across markets
Currently holds positions in CRISPR Therapeutics AG, Genocea Biosciences Inc and Adaptimmune Therapeutics PLC
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | -22% | 8.2% | 15.1% |
| Success rate | 17% | 68% | 82% |
| Transactions |
3
67% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Independent Director | CRISPR Therapeutics AG | April 1, 2015 - |
| Independent Director | Genocea Biosciences Inc | Feb. 8, 2018 - |
| Non-Executive Independent Director | Adaptimmune Therapeutics PLC | Sept. 1, 2014 - |
| Independent Director | Nevro Corp | Sept. 1, 2014 - March 19, 2019 |
Search